Neurocognitive Assessment and Rehabilitation Market Size to Reach USD 29.94 billion in 2033

The Neurocognitive Assessment and Rehabilitation market, valued at USD 14.52 billion in 2025, is expected to register revenue CAGR of 9.4%.

Request free copy of this report: https://navistratanalytics.com/request-free-sample/2042

August 17, 2026- The growing incidence of neurological and cognitive disorders is a major factor fueling market revenue growth. According to the Alzheimer's Association, more than 7 million people in the United States are currently living with Alzheimer's disease, a number projected to rise to nearly 13 million by 2050. Approximately one in nine individuals aged 65 and older is affected by Alzheimer's. At age 45, women face a one-in-five lifetime risk of developing the condition, while men have a one-in-ten risk. In addition, nearly 12 million Americans provide unpaid care for individuals with Alzheimer's or other forms of dementia.

In December 2025, Lumos Labs, the developer of the widely used Lumosity platform with over 100 million users, announced that its digital therapeutic, LumosityRx, received FDA 510(k) clearance. LumosityRx is a prescription-based mobile application designed to improve attention in adults aged 22-55 with ADHD, utilizing clinically validated versions of 13 cognitive training games that target core attention-related functions.

However, traditional neurocognitive assessment tools, such as the Mini-Mental State Examination and the Montreal Cognitive Assessment, offer limited insights into overall cognitive performance. These measurement scales are often constrained in scope and lack ecological validity, meaning they do not fully reflect real-world cognitive functioning. As a result, they may not accurately capture how individuals perform everyday activities, also known as Activities of Daily Living (ADL).

Want to Know What's Fueling the Neurocognitive Assessment and Rehabilitation Market Growth? Get Exclusive Report Insights Here: https://navistratanalytics.com/report_store/neurocognitive-assessment-and-rehabilitation-market/

Segments market overview and growth Insights
Based on component, neurocognitive assessment and rehabilitation market is segmented into hardware, solution, and services. Hardware segment contributed the largest revenue share in 2025. Equipment plays a critical role in neurological rehabilitation by accelerating and enhancing the recovery process. It helps therapists and patients meet targeted treatment goals, improve functional capabilities, and promote greater independence. The adoption of advanced technologies-such as virtual reality systems, robotic-assisted devices, and electrical stimulation tools-has further strengthened rehabilitation approaches and outcomes.

Regional market overview and growth insights
North America held the largest market share in 2025. Market growth is largely driven by the increasing prevalence of neurological and cognitive disorders, along with advancements in Digital Therapeutics (DTx) and AI-powered cognitive assessment tools. According to the Parkinson's Foundation, approximately 1.1 million people in the United States are currently living with Parkinson's disease, a number expected to rise to 1.2 million by 2030. Parkinson's disease is the second most prevalent neurological disorder after Alzheimer's disease.

Competitive Landscape and Key Competitors
The neurocognitive assessment and rehabilitation market is characterized by a fragmented structure, with several players competing across various segments and regions. List of major players included in the neurocognitive assessment and rehabilitation market report are:

o Cogstate Ltd.
o BrainCheck, Inc.
o Cambridge Cognition Ltd
o SCHUHFRIED
o CNS Vital Signs, LLC
o Lumos Labs
o MindMaze group
o Constant Therapy Health
o Neurotrack Technologies, Inc.
o Signant Health
o NeuronUP, S.L.
o MoCA Test Inc.
o Linus Health
o Viewmind
o NeuroCatch Inc.

Buy Your Exclusive Copy Now: https://navistratanalytics.com/purchase-report/2042

Major strategic developments by leading competitors
Cambridge Cognition Holdings plc: In January 2025, Cambridge Cognition Holdings plc announced the launch of its in-house Rater Training program. By integrating this capability with its electronic Clinical Outcome Assessments (eCOA) and Automated Quality Assurance technologies, the company aims to position itself as a unified platform provider while expanding its reach within the CNS clinical trials market.

BrainCheck Inc.: In March 2024, BrainCheck Inc. announced the completion of a USD 15 million funding round. The investment is intended to accelerate commercialization, drive product innovation, strengthen existing clinical data, and expand the company's presence across the healthcare ecosystem.

Unlock the Key to Transforming Your Business Strategy with Our Neurocognitive Assessment and Rehabilitation Market Insights -
• Download the report summary: https://navistratanalytics.com/request-free-sample/2042
• Request customization: https://navistratanalytics.com/request-customization/2042

Navistrat Analytics has segmented the Neurocognitive Assessment and Rehabilitation market based on detector type, technology, application, end-use, and region:
• Component Outlook (Revenue, USD Billion; 2023-2033)
o Hardware
o Services
o Solution

• Therapy Outlook (Revenue, USD Billion; 2023-2033)
o Cognitive Behavioral Therapy (CBT)
o Speech & Language Therapy
o Computer-Assisted Cognitive Rehabilitation
o Virtual Reality-Based Therapy
o Neurofeedback & Brain Stimulation Therapy
o Gamified Cognitive Training

• Application Outlook (Revenue, USD Billion; 2023-2033)
o Dementia & Alzheimer's Disease
o Stroke & Traumatic Brain Injury (TBI)
o Parkinson's Disease & Multiple Sclerosis
o Learning Disabilities
o Mental Health Disorders
o Developmental Disorders
o Healthy Aging & Preventive Brain Health

• End-Use Outlook (Revenue, USD Billion; 2023-2033)
o Hospitals & Rehabilitation Centers
o Mental Health Clinics
o Academic & Research Institutions
o Home Healthcare and Remote Users
o Corporate Wellness Programs
o Military & Veteran Healthcare Systems

• Regional Outlook (Revenue, USD Billion; 2023-2033)
o North America
a. U.S.
b. Canada
c. Mexico

o Europe
a. Germany
b. France
c. U.K.
d. Italy
e. Spain
f. Benelux
g. Nordic Countries
h. Rest of Europe

o Asia Pacific
a. China
b. India
c. Japan
d. South Korea
e. Oceania
f. ASEAN Countries
g. Rest of APAC

o Latin America
a. Brazil
b. Rest of LATAM

o Middle East & Africa
a. GCC Countries
b. South Africa
c. Israel
d. Turkey
e. Rest of MEA

Get a preview of the complete research study: https://navistratanalytics.com/report_store/neurocognitive-assessment-and-rehabilitation-market/

Bp - 5, BP Block, Sector V, Bidhannagar

At Navistrat Analytics, we provide high-quality, comprehensive syndicated and customized market research reports that deliver actionable insights and empower businesses through data-driven strategies. Choose Navistrat Analytics as your strategic growth partner for reliable market intelligence, and let us help you navigate the complexities of the market with clarity, precision, and confidence.

This release was published on openPR.